IRAK4 is a pivotal molecule linking the TLR receptors to downstream inflammatory signaling activation, thereby initiating the TLR downstream signaling cascade (45)
More broadly, any product marketed for weight loss may create delays in proper diagnosis or treatment if a person relies on it instead of seeking medical care for obesity, insulin resistance, or diabetes
Providers should monitor weight trajectory , GI tolerability (nausea, vomiting, constipation) , signs of pancreatitis (persistent severe abdominal pain vomiting), gallbladder disease (RUQ pain, fever, jaundice), hydration/renal function when clinically indicated (risk of AKI with severe GI effects), blood pressure , and glucose metrics (especially if combined with insulin or sulfonylureas due to hypoglycemia risk)
A final diagnosis of oral melanotic macule was given